Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Total Neoadjuvant Therapy in Rectal Cancer Treatment

NCT04747951 is registered in ClinicalTrials.gov with State Scientific Centre of Coloproctology, Russian Federation as lead sponsor.

NCT NCT04747951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04747951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Total Neoadjuvant Therapy in Rectal Cancer Treatment
Lead sponsor
State Scientific Centre of Coloproctology, Russian Federation
Phase
Phase 4
Overall status
Unknown status
Start date
October 30, 2020
Completion date
November 1, 2023
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer